Quick Answer
NovelStem International Corp. reported Operating Income Loss of -$238.8 thousand for the year ending 2025.
- NovelStem International Corp. showed an increase of +74.3% in Operating Income Loss from 2024 to 2025.
- This data is from NovelStem International Corp.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2009 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2010: -$2.08 million | Q1 2011: -$2.05 million | Q2 2011: -$1.33 million | Q3 2011: -$1.78 million | Q1 2012: -$889.4 thousand | Q2 2012: -$1.59 million | Q3 2012: -$1.06 million | Q1 2013: -$1.37 million | Q2 2013: -$1.20 million | Q3 2013: -$1.27 million | Q3 2021: -$133.2 thousand | Q1 2022: $171.0 thousand | Q2 2022: -$229.6 thousand | Q3 2022: -$206.2 thousand | Q1 2023: -$164.8 thousand | Q2 2023: -$2.72 million | Q3 2023: -$548.4 thousand | Q1 2024: -$180.3 thousand | Q2 2024: -$141.0 thousand | Q3 2024: -$563.6 thousand | Q1 2025: -$94.6 thousand | Q2 2025: -$64.0 thousand | Q3 2025: -$39.5 thousand.
- Over the full 9 years of available data (2009 to 2025), NovelStem International Corp.'s Operating Income Loss has grown by 97.0%.
- Historical annual values: Fiscal year 2025: -$238.8 thousand | Fiscal year 2024: -$927.9 thousand | Fiscal year 2023: -$3.53 million | Fiscal year 2022: -$422.4 thousand | Fiscal year 2021: -$495.5 thousand | Fiscal year 2012: -$5.70 million | Fiscal year 2011: -$5.81 million | Fiscal year 2010: -$7.66 million | Fiscal year 2009: -$8.01 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: